Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain Barrier
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (11) , 1767-1775
Abstract
The present study aimed to establish a humanized mouse model with which to explore OATP1A2-mediated transcellular transport of drug substrates across the blood - brain barrier (BBB), and to evaluate the usefulness of the humanized mice in preclinical studies. Sulpiride, amisulpride, sultopride, and triptans were used as probes to discriminate OATP1A2 and Oatp1a4. We generated a mouse line humanized for OATP1A2 by introducing the coding region downstream of the Oatp1a4 promoter using the CRISPR/Cas9 technique. In the mice generated, OATP1A2 mRNA in the brain was increased corresponding to disappearance of Oatp1a4. OATP1A2 was enriched in the BBB fraction where OATP1A2 was localized on both the luminal and abluminal sides of the BBB. Unfortunately, study in vivo employing sulpiride and zolmitriptan as probes did not indicate any difference in their brain-to-plasma ratio between the control and humanized mice. Quantitative targeted absolute proteomic analysis of the BBB fraction from the humanized mice revealed that almost all analyzed transporters and membrane proteins except for P-glycoprotein were expressed at similar levels to those in control mice. The quantitative levels of OATP1A2 differed depending on the peptide quantified, which suggests that incomplete translation or posttranslational modification may occur. The blood-to-brain transport of zolmitriptan, determined by brain perfusion in situ, was 1.6-fold higher in the humanized mice than in the controls, whereas that of sulpiride was not significantly changed. To our knowledge, we established a mouse line humanized for a BBB uptake transporter for the first time, and succeeded in detecting OATP1A2-mediated uptake across the BBB.Keywords
This publication has 28 references indexed in Scilit:
- A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J miceFluids and Barriers of the CNS, 2013
- Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptorsJournal of Neurochemistry, 2011
- Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain BarrierDrug Metabolism and Disposition, 2010
- Implications of ATP-binding cassette transporters for brain pharmacotherapiesTrends in Pharmacological Sciences, 2007
- Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)Journal of Biological Chemistry, 2005
- Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Human LAT1, a Subunit of System L Amino Acid Transporter: Molecular Cloning and Transport FunctionBiochemical and Biophysical Research Communications, 1999
- Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liverHepatology, 1997
- Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liverGastroenterology, 1995
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981